Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
65.26
-0.06 (-0.09%)
Oct 9, 2025, 4:00 PM EDT - Market closed
Guardant Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Net Income | -413.82 | -436.37 | -479.45 | -654.59 | -384.77 | -246.28 | Upgrade |
Depreciation & Amortization | 41.33 | 42.39 | 42.88 | 35.96 | 22.27 | 16.07 | Upgrade |
Stock-Based Compensation | 166.35 | 140.41 | 90.76 | 94.69 | 151.45 | 144.11 | Upgrade |
Other Adjustments | 31.52 | 74.58 | -33.01 | 152.91 | 42.5 | 29.84 | Upgrade |
Change in Receivables | -30.08 | -21.39 | 8.38 | 0.38 | -44.35 | -5.46 | Upgrade |
Changes in Inventories | -17.08 | -9.14 | -10.35 | -20.93 | -7.96 | -7.54 | Upgrade |
Changes in Accounts Payable | 7.93 | -2.82 | 5.19 | 60.33 | 34.8 | 0.51 | Upgrade |
Changes in Unearned Revenue | 25.32 | 18.66 | 1.73 | 9.87 | 2.78 | -3.73 | Upgrade |
Changes in Other Operating Activities | -44.71 | -46.18 | 48.89 | 11.91 | -25.73 | -31.45 | Upgrade |
Operating Cash Flow | -238.55 | -239.86 | -324.98 | -309.46 | -209.02 | -103.93 | Upgrade |
Capital Expenditures | -33.18 | -35.09 | -20.49 | -77.46 | -75.04 | -36.17 | Upgrade |
Purchases of Intangible Assets | - | - | - | - | - | -17.89 | Upgrade |
Purchases of Investments | - | -314.82 | -635.5 | -327.72 | -940.23 | -1,126 | Upgrade |
Proceeds from Sale of Investments | - | 88.6 | 1,496 | 555 | 952.11 | 562.55 | Upgrade |
Investing Cash Flow | 7.92 | -261.31 | 840.25 | 149.82 | -63.16 | -617.09 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 1,133 | Upgrade |
Long-Term Debt Repaid | - | - | - | - | - | -0.17 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | - | 1,133 | Upgrade |
Issuance of Common Stock | 2.87 | 14.84 | 503.68 | 11.94 | 17.87 | 372.35 | Upgrade |
Repurchase of Common Stock | -33.82 | -15.68 | -11.2 | -7.88 | -83.76 | -3.45 | Upgrade |
Net Common Stock Issued (Repurchased) | -30.95 | -0.84 | 492.48 | 4.06 | -65.89 | 368.91 | Upgrade |
Other Financing Activities | -0.02 | -0.15 | -15.1 | -193.16 | -0.93 | -91.18 | Upgrade |
Financing Cash Flow | -71.05 | -1 | 477.38 | -189.09 | -66.82 | 1,410 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 1.92 | -1.77 | -0.91 | -1.6 | -1.69 | 0.46 | Upgrade |
Net Cash Flow | -299.76 | -503.93 | 991.74 | -350.34 | -340.69 | 689.75 | Upgrade |
Beginning Cash & Cash Equivalents | 1,035 | 1,134 | 141.95 | 492.29 | 832.98 | 143.23 | Upgrade |
Ending Cash & Cash Equivalents | 735.48 | 629.76 | 1,134 | 141.95 | 492.29 | 832.98 | Upgrade |
Free Cash Flow | -271.73 | -274.94 | -345.46 | -386.92 | -284.05 | -140.1 | Upgrade |
FCF Margin | - | -37.20% | -61.26% | -86.07% | -76.02% | -48.86% | Upgrade |
Free Cash Flow Per Share | -2.20 | -2.24 | -3.08 | -3.79 | -2.80 | -1.44 | Upgrade |
Levered Free Cash Flow | -434.2 | -468.54 | -411.59 | -634.9 | -454.55 | 816.48 | Upgrade |
Unlevered Free Cash Flow | -482.33 | -477.07 | -497.68 | -525.64 | -460.2 | -317.65 | Upgrade |
Updated Jul 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.